Article
Expression of the von Hippel-Lindau disease tumour suppressor gene during human embryogenesis
1 May 1996
Abstract excerpt
The von Hippel-Lindau (VHL) disease product is thought to down-regulate transcription by antagonizing elongin-enhanced transcriptional elongation. Germline VHL gene mutations predispose to the development of retinal, cerebellar and spinal haemangioblastomas, renal cell carcinoma and phaeochromocytoma. In addition, somatic Inactivation of the VHL gene is frequent in sporadic renal cell carcinoma and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
